Who Is a Candidate for Allergy Drops?

Good candidates for allergy drops typically have confirmed, IgE-mediated allergic symptoms, such as allergic rhinitis from pollen, dust mites, pet dander, or mold, that aren't well controlled by avoidance and medication. Uncontrolled or severe asthma and eosinophilic esophagitis are contraindications. A board-certified allergist ultimately decides suitability after reviewing your test results and history.

By Curex Editorial TeamMedical oversight: Dr. Chet Tharpe, MD, Medical DirectorUpdated

3 peer-reviewed sources

6 min read
Quick Answer

Likely candidates have confirmed aeroallergen-driven symptoms not controlled by medication and avoidance, with no major contraindications. A board-certified allergist makes the final call after reviewing your testing and history.

  • Good candidates have confirmed, IgE-mediated environmental allergies, commonly to pollens, dust mites, pet dander, or mold, that are not well controlled by avoidance and medication.

    AAAAI

  • Uncontrolled or severe asthma is a contraindication to sublingual immunotherapy and generally must be well controlled before starting.

    ACAAI

  • Eosinophilic esophagitis is a contraindication for sublingual immunotherapy and a rare complication associated with it.

    Johns Hopkins Medicine

  • A positive allergy test alone does not confirm candidacy; an allergist correlates results with symptoms and screens for contraindications before deciding.

    AAAAI

IgE
CONFIRMED SENSITIZATION
Aero
TYPICAL TRIGGER TYPE
Provider
DECIDES CANDIDACY
EoE
KEY CONTRAINDICATION
01Overview

What Makes Someone a Candidate

Allergy drops, a form of sublingual immunotherapy, are best suited to people whose symptoms are genuinely allergic and driven by environmental allergens. The clearest candidates have confirmed, IgE-mediated sensitivities, commonly to pollens, dust mites, pet dander, or mold, that produce ongoing allergic rhinitis or rhinoconjunctivitis and aren't adequately managed by avoiding triggers and using antihistamines or nasal sprays. Immunotherapy appeals to this group because it aims to address the underlying allergic response over time rather than only masking symptoms. Confirming that profile starts with testing: Curex offers at-home allergy testing that measures allergen-specific IgE so a board-certified allergist can verify your triggers and judge whether drops make sense for you. Candidacy is not just about having allergies, though. The allergist also weighs your overall health, current asthma control, other medical conditions, and the medications you take. Allergy drops are compounded at a specialty pharmacy for each patient. The FDA does not review compounded products for safety or efficacy. A clinician's review of your suitability is essential. Importantly, candidacy is a clinical judgment, not a self-assessment: a positive test alone doesn't automatically qualify you, and the provider's review is what determines whether immunotherapy is an appropriate and safe option in your case.

Key Takeaway

Ideal candidates have confirmed environmental allergies that medication and avoidance haven't controlled, but a provider's review, not a test result alone, decides suitability.

02How It Works

Signs You May Be a Good Candidate

While only a clinician can confirm candidacy, several common patterns point toward someone who might benefit from sublingual immunotherapy. These are starting signals for a conversation with an allergist, not a checklist that qualifies you on its own.

Step 1

Confirmed environmental allergies

Testing shows IgE sensitization to aeroallergens like pollen, dust mites, pet dander, or mold that line up with your symptoms.

Step 2

Persistent or seasonal symptoms

Allergic rhinitis or rhinoconjunctivitis that recurs or lingers, affecting sleep, focus, or daily life, suggests a problem worth treating at the source.

Step 3

Limited relief from medication

Antihistamines, nasal steroids, and avoidance help only partially, or you would prefer to address the underlying response rather than medicate indefinitely.

Step 4

No major contraindications

Your asthma is well controlled and you have no condition, such as eosinophilic esophagitis, that would make sublingual immunotherapy unsuitable.

Real talk

Ready to skip the needles?

See if at-home allergy drops fit your allergies โ€” a 2-minute quiz, designed by board-certified allergists, taken under the tongue daily with no clinic visits.

  • Allergist
    Reviewed & prescribed
  • Quote required
    Confirm program pricing
  • No needles
    Under the tongue
  • HSA/FSA
    Eligible
Did you know?

Wondering if daily drops fit your allergies and schedule?

Curex's at-home allergy drops program starts with a quick eligibility check based on your symptoms and health history.

Allergy drops are compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.

Check your eligibility
09FAQ

Frequently asked questions

Can children be candidates for allergy drops?

Children can be candidates for sublingual immunotherapy in many cases, and the at-home, needle-free format is often appealing for families since it avoids the discomfort of shots. However, the appropriate minimum age depends on the specific program and the clinician's judgment, so it should not be assumed โ€” different providers set different thresholds. As with adults, a child needs confirmed, IgE-mediated environmental allergies and no contraindications such as uncontrolled asthma or eosinophilic esophagitis. A board-certified allergist evaluates the child's test results, symptoms, asthma control, and overall health before deciding. Parents should also consider whether the child can reliably hold drops under the tongue and stick to daily dosing, since consistency over years is what drives benefit. The provider makes the final candidacy determination.

Who should NOT take allergy drops?

Sublingual immunotherapy is not appropriate for everyone. People with uncontrolled or severe asthma should not start drops until their asthma is well managed, because immunotherapy can trigger reactions that are riskier with unstable airways. Eosinophilic esophagitis is a contraindication, and is itself a rare complication associated with SLIT. People taking certain medications, such as beta-blockers, or who have specific cardiovascular or immune conditions may also be advised against it or need careful evaluation. Those whose symptoms turn out not to be IgE-mediated allergies wouldn't benefit either, since immunotherapy targets allergic mechanisms. Pregnancy generally isn't a time to begin immunotherapy, though continuing established treatment may differ. A board-certified allergist screens for all of these factors during the review, which is why candidacy can't be self-determined.

Does a positive allergy test mean I'm a candidate for drops?

Not by itself. A positive test shows you are sensitized to an allergen, meaning your immune system has produced IgE against it, but sensitization doesn't automatically equal a clinically relevant allergy or candidacy for immunotherapy. Some people test positive without meaningful symptoms from that allergen. An allergist correlates your results with your actual symptom pattern, timing, and exposures to decide which sensitizations matter. They also weigh your overall health and screen for contraindications such as uncontrolled asthma. Only after that full picture comes together does the provider determine whether drops are appropriate. So a positive test is an important input, often the starting point, but candidacy is a clinical judgment that considers far more than a single lab result.

Am I a candidate for allergy drops if I have asthma?

Possibly, but it depends heavily on how well your asthma is controlled. Uncontrolled or severe asthma is a contraindication to sublingual immunotherapy, because immunotherapy can provoke reactions that are riskier when airways are already unstable. Many people with well-managed, stable asthma can still be candidates, and addressing underlying environmental allergies may even support overall control, but the assessment is individualized. An allergist will review your asthma history, current control, medications, and triggers alongside your allergy testing before deciding. If your asthma is poorly controlled, the usual approach is to get it stabilized first and then reconsider immunotherapy. This is exactly why candidacy can't be self-determined: the interaction between asthma and immunotherapy is one of the most important safety judgments a clinician makes.

Can I be a candidate for allergy drops if medications already help my symptoms?

Often yes, because candidacy is not limited to people for whom medications have completely failed. Some patients pursue immunotherapy specifically because they want to address the underlying allergic response rather than rely on antihistamines or nasal steroids indefinitely, or because medication side effects, cost, or the daily routine of taking them is burdensome. Others find medications help only partially or during peak seasons. As long as your symptoms are confirmed to be IgE-mediated environmental allergies and you have no contraindications, preferring not to medicate long-term is a legitimate reason to discuss drops. The allergist weighs your symptom burden, how well current treatment works, and your goals together. Immunotherapy and symptom medications are not mutually exclusive, and many people use medication for relief while immunotherapy works over time.

Does the type of allergen I react to affect whether I'm a candidate?

It can. Sublingual immunotherapy is best established for environmental aeroallergens, the inhaled triggers behind allergic rhinitis and rhinoconjunctivitis, such as tree, grass, and weed pollens, house dust mites, animal dander, and mold. Candidacy is most straightforward when your confirmed sensitizations fall into these categories and correlate with your symptoms. Reactions driven by something other than inhaled allergens, or symptoms that turn out not to be IgE-mediated, point away from drops, since immunotherapy works by retraining the response to specific allergens. Food allergy immunotherapy is a separate, more specialized area with its own considerations and weaker evidence than environmental treatment, so it is handled differently. The allergist uses your testing to determine which of your triggers are both relevant and appropriate to target, which is part of why an individualized review, rather than a self-assessment, defines candidacy.

Is Curex FDA-approved?

Curex's compounded allergy immunotherapy is not an FDA-approved product โ€” no compounded allergen immunotherapy is, since the FDA has approved only a small number of standardized treatments, including a few sublingual tablets for specific pollens. Compounded programs like Curex's are prepared by a licensed pharmacy under a physician's prescription, following the same general approach allergists have used off-label for decades, supported by extensive published evidence. If FDA approval status matters to your decision, ask your allergist how a compounded program compares with an FDA-approved tablet for your specific allergens.

How does Curex compare to Wyndly for allergy drops?

Curex and Wyndly are both legitimate clinics that use the same underlying treatment approach, allergist-directed testing and immunotherapy, just packaged differently, and either can help patients get relief. Wyndly offers a premium, streamlined program built on ENT protocols for environmental allergies, with an at-home finger-prick test, an in-depth video visit to start, and a self-pay model, with most patients choosing the annual plan at about $1,200 a year. Curex follows allergist protocols with ImmunoCAP testing at a lab or at home, covers both environmental and food allergies, accepts insurance, and starts from $39 a month.

How does Curex compare to Quello for allergy drops?

We don't have independently verified details about Quello's specific testing method or pricing to make a fair side-by-side comparison here. In general, when comparing any allergy-drops provider, check how they test for allergies, whether they accept insurance, their price, and how involved a board-certified allergist is in your care. Curex uses ImmunoCAP testing, accepts insurance, treats both environmental and food allergies, and starts from $39 a month โ€” compare those specifics against whatever Quello publishes before deciding.

What conditions does Curex treat with allergy drops?

Curex's sublingual immunotherapy program targets IgE-mediated environmental allergies, including tree, grass, and weed pollens, dust mites, animal dander, and mold, and some programs also address food allergies, each requiring its own evaluation. It's intended for confirmed allergic rhinitis, allergic conjunctivitis, and related allergic asthma triggers, not for non-allergic conditions or isolated food intolerances. A board-certified allergist reviews your test results and symptoms to confirm which specific allergens, if any, your program should target.

Do allergy drops actually work?

Sublingual immunotherapy has a substantial evidence base showing it can reduce allergic rhinitis symptoms and medication use over time for many patients with confirmed environmental allergies, though individual results vary and it isn't effective for everyone or for allergies outside its evidence base. It works gradually, typically over months to a few years of consistent daily dosing, rather than providing immediate relief. Your allergist can discuss the realistic evidence and timeline for your specific allergens before you start.

Questions about Curex itself?

Straight answers about the company, the evidence, what patients report, and what it costs.

No needles

Treat your allergies โ€” drops under the tongue.

Curex allergy drops are a personalized sublingual extract, prescribed by a board-certified allergist and shipped to your door โ€” taken daily at home with no needles and no routine clinic visits. Confirm your current treatment quote. HSA/FSA eligible.

Confirm your quote ยท Remaining payments for shipped treatment are collected on cancellation

Allergy drops are compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.

This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.

Allergy drops are compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.

The only FDA-approved sublingual immunotherapy products are tablets โ€” Grastek, Oralair, Ragwitek, and Odactra โ€” which are different from Curex drops.

Not sure yet if you'd qualify for allergy drops?

Curex's at-home allergy drops program starts with a quick eligibility check based on your symptoms and health history.

Check your eligibility

Allergy drops are compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.

Ready to treat your allergies at the source?

Take the free allergy quiz to find out if immunotherapy is right for you and get started with personalized treatment today.

Take Free Allergy Quiz